Skip to content
TrustList
Oncolys BioPharma logo
Investor

Oncolys BioPharma

Biopharmaceutical company developing cancer therapies and diagnostics from early detection to systemic treatment

  • Business
Oncolys BioPharma cover

About Oncolys BioPharma

Oncolys BioPharma is a biopharmaceutical company working on treatments and diagnostics for cancer. Its work spans early to late stage, covering early detection, loco-regional therapy, prognostic tests and systemic treatments. It says its mission is to help patients and physicians with effective new drugs.

What Oncolys BioPharma does

  • Cancer drug pipeline: candidates named on its site include Telomelysin (OBP-301), OBP-601 (Censavudine), OBP-2011, OBP-702 and OBP-801.
  • Diagnostics: the TelomeScan products, OBP-401 and OBP-1101.
  • Partnering: a dedicated section for collaboration with other companies.
  • Investor relations: financial statements, presentations and stock information.

Clients

Patients and physicians who need cancer treatments and tests, and investors following the company through its investor relations pages.

Key facts

  • Sector: oncology biopharmaceuticals
  • Scope: early detection through systemic treatment

Profile written by TrustList from the business's own published information, Sep 2026.

Categories & features

  • Business

Ask TrustList to introduce you to Oncolys BioPharma

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Oncolys BioPharma

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Oncolys BioPharma.

Oncolys BioPharma alternatives

Similar listings buyers compare against this one.

London private equity and venture firm that structures buyouts and growth deals for owner-managed companies

A hardware-focused venture capital firm supporting small-lot manufacturing for startups

Boutique asset manager providing private credit and direct lending to US and Canadian businesses

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

Lower middle market private equity firm with an in-house operations team, focused on women-led business services